New Build Report: Pharmaceutical-Biotech Sector Plans 205 New Facilities with $18.5 Billion in Capital Investment Potential

SUGAR LAND--October 8, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Scattered throughout North America are 205 reported new-facility builds in the Pharmaceutical-Biotech Industry, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites represent a potential total capital investment of $18.5 billion, which translates to a per-site average of about $90 million. The "potential" investment for each site includes initial construction, as well as any reported planned future expansions and subsequent phases.

Within this article: Details on key new-build projects in the Pharmaceutical-Biotech Industry, including those from major companies such as Novo Nordisk AS (NYSE:NVO) and Procter & Gamble (NYSE:PG).